Global Oral Vaccines Supply, Demand and Key Producers, 2026-2032
The global Oral Vaccines market size is expected to reach $ 3822 million by 2032, rising at a market growth of 4.2% CAGR during the forecast period (2026-2032).
Oral vaccines are immunological products administered via the oral route that induce mucosal (and often systemic) immune responses within the gastrointestinal tract. Unlike injectable vaccines, oral vaccines can take the form of live-attenuated strains, engineered microbial carriers, recombinant oral delivery platforms, or oral capsule/tablet formulations that present antigen to gut-associated lymphoid tissue (GALT), eliciting both secretory IgA and systemic antibodies. The inherent advantages of oral delivery include needle-free administration, suitability for mass campaigns and low-resource settings, and improved acceptability among recipients. Contemporary oral vaccine R&D emphasizes gut-microbiome considerations, particulate or nano-delivery systems, and engineered biological carriers to mitigate gastric degradation and immune tolerance—positioning oral vaccines as strategically important tools for infectious disease control and rapid-response immunization programs.In 2024, global Oral vaccines production reached approximately 2069 m dose, with an average global market price of around US$ 1.3 per dose.The average gross profit margin for this product is 62%.
Oral vaccines sit at the confluence of public-health policy and vaccine-delivery innovation, benefiting from policy emphasis and investment in needle-free, highly distributable immunization strategies. Their non-invasive and simple administration makes oral formats especially attractive for traveler immunizations, enteric disease prevention, and community-based campaigns. Ongoing clinical progress reported by several industry players and advances in stabilizing technologies, acid-resistant carriers, and oral delivery platforms have converted conceptual advantages into reproducible product designs—opening pathways to scale-up and cross-border deployment.
Key risks include variability in vaccine efficacy driven by gastrointestinal factors, heterogeneity of individual immune responses, and divergent regulatory expectations across jurisdictions. Such biological and regulatory complexity increases the burden of evidence required for global approval and public-program inclusion. Moreover, entrenched injectable vaccine procurement, reimbursement frameworks, and supply chains may slow the rate at which oral vaccines displace existing products; developers must therefore invest heavily in demonstrable clinical benefits, scalable manufacturing, and channel development to mitigate these constraints.
Primary healthcare providers, international aid programs, and travel medicine markets show growing demand for convenient, safe, and cost-effective vaccines. Community-level immunization prefers needle-free, easily distributable products that simplify mass campaigns and follow-up. In high-income settings, oral vaccines that demonstrate additional mucosal immunity benefits could be positioned as complementary or transmission-blocking options. End-user preferences for needle-free administration and reduced clinical resource needs enhance the appeal of oral formats, while procurement decisions increasingly weigh storage stability and cold-chain dependency.
Critical upstream components include biological carrier platforms or recombinant antigen production systems, gastro-protective excipients (acid-resistant coatings and protectants), stabilizers for ambient storage, and scalable biomanufacturing capacity. As the sector moves toward regulated, large-scale supply, manufacturers and suppliers are prioritizing batch consistency, ambient stability, and greener production methods to support deployment in low-resource settings. Safety profiling of biological carriers, regulatory compliance for genetic constructs, and excipient quality standards are central considerations in supply-chain design—ultimately determining the economic viability of moving oral vaccine candidates from trials into population-level use.
This report studies the global Oral Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Vaccines total production and demand, 2021-2032, (K Dose)
Global Oral Vaccines total production value, 2021-2032, (USD Million)
Global Oral Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Oral Vaccines consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Oral Vaccines domestic production, consumption, key domestic manufacturers and share
Global Oral Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Oral Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Oral Vaccines production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Oral Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oral Vaccines Market, By Region:
1. How big is the global Oral Vaccines market?
2. What is the demand of the global Oral Vaccines market?
3. What is the year over year growth of the global Oral Vaccines market?
4. What is the production and production value of the global Oral Vaccines market?
5. Who are the key producers in the global Oral Vaccines market?
6. What are the growth factors driving the market demand?
Oral vaccines are immunological products administered via the oral route that induce mucosal (and often systemic) immune responses within the gastrointestinal tract. Unlike injectable vaccines, oral vaccines can take the form of live-attenuated strains, engineered microbial carriers, recombinant oral delivery platforms, or oral capsule/tablet formulations that present antigen to gut-associated lymphoid tissue (GALT), eliciting both secretory IgA and systemic antibodies. The inherent advantages of oral delivery include needle-free administration, suitability for mass campaigns and low-resource settings, and improved acceptability among recipients. Contemporary oral vaccine R&D emphasizes gut-microbiome considerations, particulate or nano-delivery systems, and engineered biological carriers to mitigate gastric degradation and immune tolerance—positioning oral vaccines as strategically important tools for infectious disease control and rapid-response immunization programs.In 2024, global Oral vaccines production reached approximately 2069 m dose, with an average global market price of around US$ 1.3 per dose.The average gross profit margin for this product is 62%.
Oral vaccines sit at the confluence of public-health policy and vaccine-delivery innovation, benefiting from policy emphasis and investment in needle-free, highly distributable immunization strategies. Their non-invasive and simple administration makes oral formats especially attractive for traveler immunizations, enteric disease prevention, and community-based campaigns. Ongoing clinical progress reported by several industry players and advances in stabilizing technologies, acid-resistant carriers, and oral delivery platforms have converted conceptual advantages into reproducible product designs—opening pathways to scale-up and cross-border deployment.
Key risks include variability in vaccine efficacy driven by gastrointestinal factors, heterogeneity of individual immune responses, and divergent regulatory expectations across jurisdictions. Such biological and regulatory complexity increases the burden of evidence required for global approval and public-program inclusion. Moreover, entrenched injectable vaccine procurement, reimbursement frameworks, and supply chains may slow the rate at which oral vaccines displace existing products; developers must therefore invest heavily in demonstrable clinical benefits, scalable manufacturing, and channel development to mitigate these constraints.
Primary healthcare providers, international aid programs, and travel medicine markets show growing demand for convenient, safe, and cost-effective vaccines. Community-level immunization prefers needle-free, easily distributable products that simplify mass campaigns and follow-up. In high-income settings, oral vaccines that demonstrate additional mucosal immunity benefits could be positioned as complementary or transmission-blocking options. End-user preferences for needle-free administration and reduced clinical resource needs enhance the appeal of oral formats, while procurement decisions increasingly weigh storage stability and cold-chain dependency.
Critical upstream components include biological carrier platforms or recombinant antigen production systems, gastro-protective excipients (acid-resistant coatings and protectants), stabilizers for ambient storage, and scalable biomanufacturing capacity. As the sector moves toward regulated, large-scale supply, manufacturers and suppliers are prioritizing batch consistency, ambient stability, and greener production methods to support deployment in low-resource settings. Safety profiling of biological carriers, regulatory compliance for genetic constructs, and excipient quality standards are central considerations in supply-chain design—ultimately determining the economic viability of moving oral vaccine candidates from trials into population-level use.
This report studies the global Oral Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Vaccines total production and demand, 2021-2032, (K Dose)
Global Oral Vaccines total production value, 2021-2032, (USD Million)
Global Oral Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Oral Vaccines consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Oral Vaccines domestic production, consumption, key domestic manufacturers and share
Global Oral Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Oral Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Oral Vaccines production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Oral Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oral Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Other
- Public
- Private
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- CNBG
1. How big is the global Oral Vaccines market?
2. What is the demand of the global Oral Vaccines market?
3. What is the year over year growth of the global Oral Vaccines market?
4. What is the production and production value of the global Oral Vaccines market?
5. Who are the key producers in the global Oral Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oral Vaccines Introduction
1.2 World Oral Vaccines Supply & Forecast
1.2.1 World Oral Vaccines Production Value (2021 & 2025 & 2032)
1.2.2 World Oral Vaccines Production (2021-2032)
1.2.3 World Oral Vaccines Pricing Trends (2021-2032)
1.3 World Oral Vaccines Production by Region (Based on Production Site)
1.3.1 World Oral Vaccines Production Value by Region (2021-2032)
1.3.2 World Oral Vaccines Production by Region (2021-2032)
1.3.3 World Oral Vaccines Average Price by Region (2021-2032)
1.3.4 North America Oral Vaccines Production (2021-2032)
1.3.5 Europe Oral Vaccines Production (2021-2032)
1.3.6 Southeast Asia Oral Vaccines Production (2021-2032)
1.3.7 Japan Oral Vaccines Production (2021-2032)
1.3.8 China Oral Vaccines Production (2021-2032)
1.3.9 South Korea Oral Vaccines Production (2021-2032)
1.3.10 India Oral Vaccines Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World Oral Vaccines Demand (2021-2032)
2.2 World Oral Vaccines Consumption by Region
2.2.1 World Oral Vaccines Consumption by Region (2021-2026)
2.2.2 World Oral Vaccines Consumption Forecast by Region (2027-2032)
2.3 United States Oral Vaccines Consumption (2021-2032)
2.4 China Oral Vaccines Consumption (2021-2032)
2.5 Europe Oral Vaccines Consumption (2021-2032)
2.6 Japan Oral Vaccines Consumption (2021-2032)
2.7 South Korea Oral Vaccines Consumption (2021-2032)
2.8 ASEAN Oral Vaccines Consumption (2021-2032)
2.9 India Oral Vaccines Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Vaccines Production Value by Manufacturer (2021-2026)
3.2 World Oral Vaccines Production by Manufacturer (2021-2026)
3.3 World Oral Vaccines Average Price by Manufacturer (2021-2026)
3.4 Oral Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Vaccines in 2025
3.5.3 Global Concentration Ratios (CR8) for Oral Vaccines in 2025
3.6 Oral Vaccines Market: Overall Company Footprint Analysis
3.6.1 Oral Vaccines Market: Region Footprint
3.6.2 Oral Vaccines Market: Company Product Type Footprint
3.6.3 Oral Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Vaccines Production Value Comparison
4.1.1 United States VS China: Oral Vaccines Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Oral Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Oral Vaccines Production Comparison
4.2.1 United States VS China: Oral Vaccines Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oral Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Oral Vaccines Consumption Comparison
4.3.1 United States VS China: Oral Vaccines Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Oral Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Oral Vaccines Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Oral Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Vaccines Production Value (2021-2026)
4.4.3 United States Based Manufacturers Oral Vaccines Production (2021-2026)
4.5 China Based Oral Vaccines Manufacturers and Market Share
4.5.1 China Based Oral Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Vaccines Production Value (2021-2026)
4.5.3 China Based Manufacturers Oral Vaccines Production (2021-2026)
4.6 Rest of World Based Oral Vaccines Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Oral Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Vaccines Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Oral Vaccines Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Vaccines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Rotavirus Vaccine
5.2.2 Cholera Vaccine
5.2.3 Oral Polio Vaccine
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Oral Vaccines Production by Type (2021-2032)
5.3.2 World Oral Vaccines Production Value by Type (2021-2032)
5.3.3 World Oral Vaccines Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral Vaccines Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Public
6.2.2 Private
6.3 Market Segment by Application
6.3.1 World Oral Vaccines Production by Application (2021-2032)
6.3.2 World Oral Vaccines Production Value by Application (2021-2032)
6.3.3 World Oral Vaccines Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Oral Vaccines Product and Services
7.1.4 Merck Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Oral Vaccines Product and Services
7.2.4 GSK Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Oral Vaccines Product and Services
7.3.4 Sanofi Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Details
7.4.2 Lanzhou Institute Major Business
7.4.3 Lanzhou Institute Oral Vaccines Product and Services
7.4.4 Lanzhou Institute Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Lanzhou Institute Recent Developments/Updates
7.4.6 Lanzhou Institute Competitive Strengths & Weaknesses
7.5 Serum Institute
7.5.1 Serum Institute Details
7.5.2 Serum Institute Major Business
7.5.3 Serum Institute Oral Vaccines Product and Services
7.5.4 Serum Institute Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Serum Institute Recent Developments/Updates
7.5.6 Serum Institute Competitive Strengths & Weaknesses
7.6 Valneva
7.6.1 Valneva Details
7.6.2 Valneva Major Business
7.6.3 Valneva Oral Vaccines Product and Services
7.6.4 Valneva Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Valneva Recent Developments/Updates
7.6.6 Valneva Competitive Strengths & Weaknesses
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Details
7.7.2 Shanghai United Cell Major Business
7.7.3 Shanghai United Cell Oral Vaccines Product and Services
7.7.4 Shanghai United Cell Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Shanghai United Cell Recent Developments/Updates
7.7.6 Shanghai United Cell Competitive Strengths & Weaknesses
7.8 Bibcol
7.8.1 Bibcol Details
7.8.2 Bibcol Major Business
7.8.3 Bibcol Oral Vaccines Product and Services
7.8.4 Bibcol Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Bibcol Recent Developments/Updates
7.8.6 Bibcol Competitive Strengths & Weaknesses
7.9 PaxVax
7.9.1 PaxVax Details
7.9.2 PaxVax Major Business
7.9.3 PaxVax Oral Vaccines Product and Services
7.9.4 PaxVax Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 PaxVax Recent Developments/Updates
7.9.6 PaxVax Competitive Strengths & Weaknesses
7.10 Vabiotech
7.10.1 Vabiotech Details
7.10.2 Vabiotech Major Business
7.10.3 Vabiotech Oral Vaccines Product and Services
7.10.4 Vabiotech Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Vabiotech Recent Developments/Updates
7.10.6 Vabiotech Competitive Strengths & Weaknesses
7.11 Tiantan Biological
7.11.1 Tiantan Biological Details
7.11.2 Tiantan Biological Major Business
7.11.3 Tiantan Biological Oral Vaccines Product and Services
7.11.4 Tiantan Biological Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Tiantan Biological Recent Developments/Updates
7.11.6 Tiantan Biological Competitive Strengths & Weaknesses
7.12 EuBiologics
7.12.1 EuBiologics Details
7.12.2 EuBiologics Major Business
7.12.3 EuBiologics Oral Vaccines Product and Services
7.12.4 EuBiologics Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 EuBiologics Recent Developments/Updates
7.12.6 EuBiologics Competitive Strengths & Weaknesses
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Details
7.13.2 Panacea Biotec Ltd Major Business
7.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services
7.13.4 Panacea Biotec Ltd Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Panacea Biotec Ltd Recent Developments/Updates
7.13.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
7.14 Bio-Med
7.14.1 Bio-Med Details
7.14.2 Bio-Med Major Business
7.14.3 Bio-Med Oral Vaccines Product and Services
7.14.4 Bio-Med Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Bio-Med Recent Developments/Updates
7.14.6 Bio-Med Competitive Strengths & Weaknesses
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Details
7.15.2 Halfkin Bio-Pharmaceuticals Major Business
7.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
7.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7.15.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
7.16 CNBG
7.16.1 CNBG Details
7.16.2 CNBG Major Business
7.16.3 CNBG Oral Vaccines Product and Services
7.16.4 CNBG Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 CNBG Recent Developments/Updates
7.16.6 CNBG Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oral Vaccines Industry Chain
8.2 Oral Vaccines Upstream Analysis
8.2.1 Oral Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Oral Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oral Vaccines Production Mode
8.6 Oral Vaccines Procurement Model
8.7 Oral Vaccines Industry Sales Model and Sales Channels
8.7.1 Oral Vaccines Sales Model
8.7.2 Oral Vaccines Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oral Vaccines Introduction
1.2 World Oral Vaccines Supply & Forecast
1.2.1 World Oral Vaccines Production Value (2021 & 2025 & 2032)
1.2.2 World Oral Vaccines Production (2021-2032)
1.2.3 World Oral Vaccines Pricing Trends (2021-2032)
1.3 World Oral Vaccines Production by Region (Based on Production Site)
1.3.1 World Oral Vaccines Production Value by Region (2021-2032)
1.3.2 World Oral Vaccines Production by Region (2021-2032)
1.3.3 World Oral Vaccines Average Price by Region (2021-2032)
1.3.4 North America Oral Vaccines Production (2021-2032)
1.3.5 Europe Oral Vaccines Production (2021-2032)
1.3.6 Southeast Asia Oral Vaccines Production (2021-2032)
1.3.7 Japan Oral Vaccines Production (2021-2032)
1.3.8 China Oral Vaccines Production (2021-2032)
1.3.9 South Korea Oral Vaccines Production (2021-2032)
1.3.10 India Oral Vaccines Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World Oral Vaccines Demand (2021-2032)
2.2 World Oral Vaccines Consumption by Region
2.2.1 World Oral Vaccines Consumption by Region (2021-2026)
2.2.2 World Oral Vaccines Consumption Forecast by Region (2027-2032)
2.3 United States Oral Vaccines Consumption (2021-2032)
2.4 China Oral Vaccines Consumption (2021-2032)
2.5 Europe Oral Vaccines Consumption (2021-2032)
2.6 Japan Oral Vaccines Consumption (2021-2032)
2.7 South Korea Oral Vaccines Consumption (2021-2032)
2.8 ASEAN Oral Vaccines Consumption (2021-2032)
2.9 India Oral Vaccines Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oral Vaccines Production Value by Manufacturer (2021-2026)
3.2 World Oral Vaccines Production by Manufacturer (2021-2026)
3.3 World Oral Vaccines Average Price by Manufacturer (2021-2026)
3.4 Oral Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Vaccines in 2025
3.5.3 Global Concentration Ratios (CR8) for Oral Vaccines in 2025
3.6 Oral Vaccines Market: Overall Company Footprint Analysis
3.6.1 Oral Vaccines Market: Region Footprint
3.6.2 Oral Vaccines Market: Company Product Type Footprint
3.6.3 Oral Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oral Vaccines Production Value Comparison
4.1.1 United States VS China: Oral Vaccines Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Oral Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Oral Vaccines Production Comparison
4.2.1 United States VS China: Oral Vaccines Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oral Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Oral Vaccines Consumption Comparison
4.3.1 United States VS China: Oral Vaccines Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Oral Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Oral Vaccines Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Oral Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Vaccines Production Value (2021-2026)
4.4.3 United States Based Manufacturers Oral Vaccines Production (2021-2026)
4.5 China Based Oral Vaccines Manufacturers and Market Share
4.5.1 China Based Oral Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Vaccines Production Value (2021-2026)
4.5.3 China Based Manufacturers Oral Vaccines Production (2021-2026)
4.6 Rest of World Based Oral Vaccines Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Oral Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Vaccines Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Oral Vaccines Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Oral Vaccines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Rotavirus Vaccine
5.2.2 Cholera Vaccine
5.2.3 Oral Polio Vaccine
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Oral Vaccines Production by Type (2021-2032)
5.3.2 World Oral Vaccines Production Value by Type (2021-2032)
5.3.3 World Oral Vaccines Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oral Vaccines Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Public
6.2.2 Private
6.3 Market Segment by Application
6.3.1 World Oral Vaccines Production by Application (2021-2032)
6.3.2 World Oral Vaccines Production Value by Application (2021-2032)
6.3.3 World Oral Vaccines Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Oral Vaccines Product and Services
7.1.4 Merck Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Oral Vaccines Product and Services
7.2.4 GSK Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Oral Vaccines Product and Services
7.3.4 Sanofi Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Details
7.4.2 Lanzhou Institute Major Business
7.4.3 Lanzhou Institute Oral Vaccines Product and Services
7.4.4 Lanzhou Institute Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Lanzhou Institute Recent Developments/Updates
7.4.6 Lanzhou Institute Competitive Strengths & Weaknesses
7.5 Serum Institute
7.5.1 Serum Institute Details
7.5.2 Serum Institute Major Business
7.5.3 Serum Institute Oral Vaccines Product and Services
7.5.4 Serum Institute Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Serum Institute Recent Developments/Updates
7.5.6 Serum Institute Competitive Strengths & Weaknesses
7.6 Valneva
7.6.1 Valneva Details
7.6.2 Valneva Major Business
7.6.3 Valneva Oral Vaccines Product and Services
7.6.4 Valneva Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Valneva Recent Developments/Updates
7.6.6 Valneva Competitive Strengths & Weaknesses
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Details
7.7.2 Shanghai United Cell Major Business
7.7.3 Shanghai United Cell Oral Vaccines Product and Services
7.7.4 Shanghai United Cell Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Shanghai United Cell Recent Developments/Updates
7.7.6 Shanghai United Cell Competitive Strengths & Weaknesses
7.8 Bibcol
7.8.1 Bibcol Details
7.8.2 Bibcol Major Business
7.8.3 Bibcol Oral Vaccines Product and Services
7.8.4 Bibcol Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Bibcol Recent Developments/Updates
7.8.6 Bibcol Competitive Strengths & Weaknesses
7.9 PaxVax
7.9.1 PaxVax Details
7.9.2 PaxVax Major Business
7.9.3 PaxVax Oral Vaccines Product and Services
7.9.4 PaxVax Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 PaxVax Recent Developments/Updates
7.9.6 PaxVax Competitive Strengths & Weaknesses
7.10 Vabiotech
7.10.1 Vabiotech Details
7.10.2 Vabiotech Major Business
7.10.3 Vabiotech Oral Vaccines Product and Services
7.10.4 Vabiotech Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Vabiotech Recent Developments/Updates
7.10.6 Vabiotech Competitive Strengths & Weaknesses
7.11 Tiantan Biological
7.11.1 Tiantan Biological Details
7.11.2 Tiantan Biological Major Business
7.11.3 Tiantan Biological Oral Vaccines Product and Services
7.11.4 Tiantan Biological Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Tiantan Biological Recent Developments/Updates
7.11.6 Tiantan Biological Competitive Strengths & Weaknesses
7.12 EuBiologics
7.12.1 EuBiologics Details
7.12.2 EuBiologics Major Business
7.12.3 EuBiologics Oral Vaccines Product and Services
7.12.4 EuBiologics Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 EuBiologics Recent Developments/Updates
7.12.6 EuBiologics Competitive Strengths & Weaknesses
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Details
7.13.2 Panacea Biotec Ltd Major Business
7.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services
7.13.4 Panacea Biotec Ltd Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 Panacea Biotec Ltd Recent Developments/Updates
7.13.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
7.14 Bio-Med
7.14.1 Bio-Med Details
7.14.2 Bio-Med Major Business
7.14.3 Bio-Med Oral Vaccines Product and Services
7.14.4 Bio-Med Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Bio-Med Recent Developments/Updates
7.14.6 Bio-Med Competitive Strengths & Weaknesses
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Details
7.15.2 Halfkin Bio-Pharmaceuticals Major Business
7.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
7.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7.15.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
7.16 CNBG
7.16.1 CNBG Details
7.16.2 CNBG Major Business
7.16.3 CNBG Oral Vaccines Product and Services
7.16.4 CNBG Oral Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.16.5 CNBG Recent Developments/Updates
7.16.6 CNBG Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oral Vaccines Industry Chain
8.2 Oral Vaccines Upstream Analysis
8.2.1 Oral Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Oral Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oral Vaccines Production Mode
8.6 Oral Vaccines Procurement Model
8.7 Oral Vaccines Industry Sales Model and Sales Channels
8.7.1 Oral Vaccines Sales Model
8.7.2 Oral Vaccines Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oral Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Oral Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World Oral Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World Oral Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World Oral Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World Oral Vaccines Production by Region (2021-2026) & (K Dose)
Table 7. World Oral Vaccines Production by Region (2027-2032) & (K Dose)
Table 8. World Oral Vaccines Production Market Share by Region (2021-2026)
Table 9. World Oral Vaccines Production Market Share by Region (2027-2032)
Table 10. World Oral Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Oral Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Oral Vaccines Major Market Trends
Table 13. World Oral Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Oral Vaccines Consumption by Region (2021-2026) & (K Dose)
Table 15. World Oral Vaccines Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Oral Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Oral Vaccines Producers in 2025
Table 18. World Oral Vaccines Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Oral Vaccines Producers in 2025
Table 20. World Oral Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Oral Vaccines Company Evaluation Quadrant
Table 22. World Oral Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Oral Vaccines Production Site of Key Manufacturer
Table 24. Oral Vaccines Market: Company Product Type Footprint
Table 25. Oral Vaccines Market: Company Product Application Footprint
Table 26. Oral Vaccines Competitive Factors
Table 27. Oral Vaccines New Entrant and Capacity Expansion Plans
Table 28. Oral Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Oral Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Oral Vaccines Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Oral Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Oral Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Oral Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Oral Vaccines Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Oral Vaccines Production Market Share (2021-2026)
Table 37. China Based Oral Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Oral Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Oral Vaccines Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Oral Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based Oral Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Oral Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Oral Vaccines Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Oral Vaccines Production Market Share (2021-2026)
Table 47. World Oral Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Oral Vaccines Production by Type (2021-2026) & (K Dose)
Table 49. World Oral Vaccines Production by Type (2027-2032) & (K Dose)
Table 50. World Oral Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World Oral Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World Oral Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Oral Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Oral Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Oral Vaccines Production by Application (2021-2026) & (K Dose)
Table 56. World Oral Vaccines Production by Application (2027-2032) & (K Dose)
Table 57. World Oral Vaccines Production Value by Application (2021-2026) & (USD Million)
Table 58. World Oral Vaccines Production Value by Application (2027-2032) & (USD Million)
Table 59. World Oral Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 60. World Oral Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Oral Vaccines Product and Services
Table 64. Merck Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Oral Vaccines Product and Services
Table 70. GSK Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Oral Vaccines Product and Services
Table 76. Sanofi Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 80. Lanzhou Institute Major Business
Table 81. Lanzhou Institute Oral Vaccines Product and Services
Table 82. Lanzhou Institute Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Lanzhou Institute Recent Developments/Updates
Table 84. Lanzhou Institute Competitive Strengths & Weaknesses
Table 85. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute Major Business
Table 87. Serum Institute Oral Vaccines Product and Services
Table 88. Serum Institute Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Serum Institute Recent Developments/Updates
Table 90. Serum Institute Competitive Strengths & Weaknesses
Table 91. Valneva Basic Information, Manufacturing Base and Competitors
Table 92. Valneva Major Business
Table 93. Valneva Oral Vaccines Product and Services
Table 94. Valneva Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Valneva Recent Developments/Updates
Table 96. Valneva Competitive Strengths & Weaknesses
Table 97. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai United Cell Major Business
Table 99. Shanghai United Cell Oral Vaccines Product and Services
Table 100. Shanghai United Cell Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Shanghai United Cell Recent Developments/Updates
Table 102. Shanghai United Cell Competitive Strengths & Weaknesses
Table 103. Bibcol Basic Information, Manufacturing Base and Competitors
Table 104. Bibcol Major Business
Table 105. Bibcol Oral Vaccines Product and Services
Table 106. Bibcol Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Bibcol Recent Developments/Updates
Table 108. Bibcol Competitive Strengths & Weaknesses
Table 109. PaxVax Basic Information, Manufacturing Base and Competitors
Table 110. PaxVax Major Business
Table 111. PaxVax Oral Vaccines Product and Services
Table 112. PaxVax Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. PaxVax Recent Developments/Updates
Table 114. PaxVax Competitive Strengths & Weaknesses
Table 115. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 116. Vabiotech Major Business
Table 117. Vabiotech Oral Vaccines Product and Services
Table 118. Vabiotech Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Vabiotech Recent Developments/Updates
Table 120. Vabiotech Competitive Strengths & Weaknesses
Table 121. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 122. Tiantan Biological Major Business
Table 123. Tiantan Biological Oral Vaccines Product and Services
Table 124. Tiantan Biological Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Tiantan Biological Recent Developments/Updates
Table 126. Tiantan Biological Competitive Strengths & Weaknesses
Table 127. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 128. EuBiologics Major Business
Table 129. EuBiologics Oral Vaccines Product and Services
Table 130. EuBiologics Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. EuBiologics Recent Developments/Updates
Table 132. EuBiologics Competitive Strengths & Weaknesses
Table 133. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Panacea Biotec Ltd Major Business
Table 135. Panacea Biotec Ltd Oral Vaccines Product and Services
Table 136. Panacea Biotec Ltd Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Panacea Biotec Ltd Recent Developments/Updates
Table 138. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 139. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 140. Bio-Med Major Business
Table 141. Bio-Med Oral Vaccines Product and Services
Table 142. Bio-Med Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Bio-Med Recent Developments/Updates
Table 144. Bio-Med Competitive Strengths & Weaknesses
Table 145. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Halfkin Bio-Pharmaceuticals Major Business
Table 147. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
Table 148. Halfkin Bio-Pharmaceuticals Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 150. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. CNBG Basic Information, Manufacturing Base and Competitors
Table 152. CNBG Major Business
Table 153. CNBG Oral Vaccines Product and Services
Table 154. CNBG Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. CNBG Recent Developments/Updates
Table 156. CNBG Competitive Strengths & Weaknesses
Table 157. Global Key Players of Oral Vaccines Upstream (Raw Materials)
Table 158. Global Oral Vaccines Typical Customers
Table 159. Oral Vaccines Typical Distributors
Table 1. World Oral Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Oral Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World Oral Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World Oral Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World Oral Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World Oral Vaccines Production by Region (2021-2026) & (K Dose)
Table 7. World Oral Vaccines Production by Region (2027-2032) & (K Dose)
Table 8. World Oral Vaccines Production Market Share by Region (2021-2026)
Table 9. World Oral Vaccines Production Market Share by Region (2027-2032)
Table 10. World Oral Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Oral Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Oral Vaccines Major Market Trends
Table 13. World Oral Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Oral Vaccines Consumption by Region (2021-2026) & (K Dose)
Table 15. World Oral Vaccines Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Oral Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Oral Vaccines Producers in 2025
Table 18. World Oral Vaccines Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Oral Vaccines Producers in 2025
Table 20. World Oral Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Oral Vaccines Company Evaluation Quadrant
Table 22. World Oral Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Oral Vaccines Production Site of Key Manufacturer
Table 24. Oral Vaccines Market: Company Product Type Footprint
Table 25. Oral Vaccines Market: Company Product Application Footprint
Table 26. Oral Vaccines Competitive Factors
Table 27. Oral Vaccines New Entrant and Capacity Expansion Plans
Table 28. Oral Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Oral Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Oral Vaccines Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Oral Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Oral Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Oral Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Oral Vaccines Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Oral Vaccines Production Market Share (2021-2026)
Table 37. China Based Oral Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Oral Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Oral Vaccines Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Oral Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based Oral Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Oral Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Oral Vaccines Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Oral Vaccines Production Market Share (2021-2026)
Table 47. World Oral Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Oral Vaccines Production by Type (2021-2026) & (K Dose)
Table 49. World Oral Vaccines Production by Type (2027-2032) & (K Dose)
Table 50. World Oral Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World Oral Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World Oral Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Oral Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Oral Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Oral Vaccines Production by Application (2021-2026) & (K Dose)
Table 56. World Oral Vaccines Production by Application (2027-2032) & (K Dose)
Table 57. World Oral Vaccines Production Value by Application (2021-2026) & (USD Million)
Table 58. World Oral Vaccines Production Value by Application (2027-2032) & (USD Million)
Table 59. World Oral Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 60. World Oral Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Oral Vaccines Product and Services
Table 64. Merck Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Oral Vaccines Product and Services
Table 70. GSK Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Oral Vaccines Product and Services
Table 76. Sanofi Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 80. Lanzhou Institute Major Business
Table 81. Lanzhou Institute Oral Vaccines Product and Services
Table 82. Lanzhou Institute Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Lanzhou Institute Recent Developments/Updates
Table 84. Lanzhou Institute Competitive Strengths & Weaknesses
Table 85. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute Major Business
Table 87. Serum Institute Oral Vaccines Product and Services
Table 88. Serum Institute Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Serum Institute Recent Developments/Updates
Table 90. Serum Institute Competitive Strengths & Weaknesses
Table 91. Valneva Basic Information, Manufacturing Base and Competitors
Table 92. Valneva Major Business
Table 93. Valneva Oral Vaccines Product and Services
Table 94. Valneva Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Valneva Recent Developments/Updates
Table 96. Valneva Competitive Strengths & Weaknesses
Table 97. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai United Cell Major Business
Table 99. Shanghai United Cell Oral Vaccines Product and Services
Table 100. Shanghai United Cell Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Shanghai United Cell Recent Developments/Updates
Table 102. Shanghai United Cell Competitive Strengths & Weaknesses
Table 103. Bibcol Basic Information, Manufacturing Base and Competitors
Table 104. Bibcol Major Business
Table 105. Bibcol Oral Vaccines Product and Services
Table 106. Bibcol Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Bibcol Recent Developments/Updates
Table 108. Bibcol Competitive Strengths & Weaknesses
Table 109. PaxVax Basic Information, Manufacturing Base and Competitors
Table 110. PaxVax Major Business
Table 111. PaxVax Oral Vaccines Product and Services
Table 112. PaxVax Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. PaxVax Recent Developments/Updates
Table 114. PaxVax Competitive Strengths & Weaknesses
Table 115. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 116. Vabiotech Major Business
Table 117. Vabiotech Oral Vaccines Product and Services
Table 118. Vabiotech Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Vabiotech Recent Developments/Updates
Table 120. Vabiotech Competitive Strengths & Weaknesses
Table 121. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 122. Tiantan Biological Major Business
Table 123. Tiantan Biological Oral Vaccines Product and Services
Table 124. Tiantan Biological Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Tiantan Biological Recent Developments/Updates
Table 126. Tiantan Biological Competitive Strengths & Weaknesses
Table 127. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 128. EuBiologics Major Business
Table 129. EuBiologics Oral Vaccines Product and Services
Table 130. EuBiologics Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. EuBiologics Recent Developments/Updates
Table 132. EuBiologics Competitive Strengths & Weaknesses
Table 133. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Panacea Biotec Ltd Major Business
Table 135. Panacea Biotec Ltd Oral Vaccines Product and Services
Table 136. Panacea Biotec Ltd Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Panacea Biotec Ltd Recent Developments/Updates
Table 138. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 139. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 140. Bio-Med Major Business
Table 141. Bio-Med Oral Vaccines Product and Services
Table 142. Bio-Med Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Bio-Med Recent Developments/Updates
Table 144. Bio-Med Competitive Strengths & Weaknesses
Table 145. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Halfkin Bio-Pharmaceuticals Major Business
Table 147. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services
Table 148. Halfkin Bio-Pharmaceuticals Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 150. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. CNBG Basic Information, Manufacturing Base and Competitors
Table 152. CNBG Major Business
Table 153. CNBG Oral Vaccines Product and Services
Table 154. CNBG Oral Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. CNBG Recent Developments/Updates
Table 156. CNBG Competitive Strengths & Weaknesses
Table 157. Global Key Players of Oral Vaccines Upstream (Raw Materials)
Table 158. Global Oral Vaccines Typical Customers
Table 159. Oral Vaccines Typical Distributors
LIST OF FIGURES
Figure 1. Oral Vaccines Picture
Figure 2. World Oral Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oral Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Oral Vaccines Production (2021-2032) & (K Dose)
Figure 5. World Oral Vaccines Average Price (2021-2032) & (US$/Dose)
Figure 6. World Oral Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World Oral Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America Oral Vaccines Production (2021-2032) & (K Dose)
Figure 9. Europe Oral Vaccines Production (2021-2032) & (K Dose)
Figure 10. Southeast Asia Oral Vaccines Production (2021-2032) & (K Dose)
Figure 11. Japan Oral Vaccines Production (2021-2032) & (K Dose)
Figure 12. China Oral Vaccines Production (2021-2032) & (K Dose)
Figure 13. South Korea Oral Vaccines Production (2021-2032) & (K Dose)
Figure 14. India Oral Vaccines Production (2021-2032) & (K Dose)
Figure 15. Oral Vaccines Market Drivers
Figure 16. Factors Affecting Demand
Figure 17. World Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 18. World Oral Vaccines Consumption Market Share by Region (2021-2032)
Figure 19. United States Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 20. China Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 21. Europe Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 22. Japan Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 23. South Korea Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 24. ASEAN Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 25. India Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 26. Producer Shipments of Oral Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 27. Global Four-firm Concentration Ratios (CR4) for Oral Vaccines Markets in 2025
Figure 28. Global Four-firm Concentration Ratios (CR8) for Oral Vaccines Markets in 2025
Figure 29. United States VS China: Oral Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Oral Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States VS China: Oral Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 32. United States Based Manufacturers Oral Vaccines Production Market Share 2025
Figure 33. China Based Manufacturers Oral Vaccines Production Market Share 2025
Figure 34. Rest of World Based Manufacturers Oral Vaccines Production Market Share 2025
Figure 35. World Oral Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 36. World Oral Vaccines Production Value Market Share by Type in 2025
Figure 37. Rotavirus Vaccine
Figure 38. Cholera Vaccine
Figure 39. Oral Polio Vaccine
Figure 40. Other
Figure 41. World Oral Vaccines Production Market Share by Type (2021-2032)
Figure 42. World Oral Vaccines Production Value Market Share by Type (2021-2032)
Figure 43. World Oral Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 44. World Oral Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Oral Vaccines Production Value Market Share by Application in 2025
Figure 46. Public
Figure 47. Private
Figure 48. World Oral Vaccines Production Market Share by Application (2021-2032)
Figure 49. World Oral Vaccines Production Value Market Share by Application (2021-2032)
Figure 50. World Oral Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 51. Oral Vaccines Industry Chain
Figure 52. Oral Vaccines Procurement Model
Figure 53. Oral Vaccines Sales Model
Figure 54. Oral Vaccines Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Oral Vaccines Picture
Figure 2. World Oral Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oral Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Oral Vaccines Production (2021-2032) & (K Dose)
Figure 5. World Oral Vaccines Average Price (2021-2032) & (US$/Dose)
Figure 6. World Oral Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World Oral Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America Oral Vaccines Production (2021-2032) & (K Dose)
Figure 9. Europe Oral Vaccines Production (2021-2032) & (K Dose)
Figure 10. Southeast Asia Oral Vaccines Production (2021-2032) & (K Dose)
Figure 11. Japan Oral Vaccines Production (2021-2032) & (K Dose)
Figure 12. China Oral Vaccines Production (2021-2032) & (K Dose)
Figure 13. South Korea Oral Vaccines Production (2021-2032) & (K Dose)
Figure 14. India Oral Vaccines Production (2021-2032) & (K Dose)
Figure 15. Oral Vaccines Market Drivers
Figure 16. Factors Affecting Demand
Figure 17. World Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 18. World Oral Vaccines Consumption Market Share by Region (2021-2032)
Figure 19. United States Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 20. China Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 21. Europe Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 22. Japan Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 23. South Korea Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 24. ASEAN Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 25. India Oral Vaccines Consumption (2021-2032) & (K Dose)
Figure 26. Producer Shipments of Oral Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 27. Global Four-firm Concentration Ratios (CR4) for Oral Vaccines Markets in 2025
Figure 28. Global Four-firm Concentration Ratios (CR8) for Oral Vaccines Markets in 2025
Figure 29. United States VS China: Oral Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Oral Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States VS China: Oral Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 32. United States Based Manufacturers Oral Vaccines Production Market Share 2025
Figure 33. China Based Manufacturers Oral Vaccines Production Market Share 2025
Figure 34. Rest of World Based Manufacturers Oral Vaccines Production Market Share 2025
Figure 35. World Oral Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 36. World Oral Vaccines Production Value Market Share by Type in 2025
Figure 37. Rotavirus Vaccine
Figure 38. Cholera Vaccine
Figure 39. Oral Polio Vaccine
Figure 40. Other
Figure 41. World Oral Vaccines Production Market Share by Type (2021-2032)
Figure 42. World Oral Vaccines Production Value Market Share by Type (2021-2032)
Figure 43. World Oral Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 44. World Oral Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Oral Vaccines Production Value Market Share by Application in 2025
Figure 46. Public
Figure 47. Private
Figure 48. World Oral Vaccines Production Market Share by Application (2021-2032)
Figure 49. World Oral Vaccines Production Value Market Share by Application (2021-2032)
Figure 50. World Oral Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 51. Oral Vaccines Industry Chain
Figure 52. Oral Vaccines Procurement Model
Figure 53. Oral Vaccines Sales Model
Figure 54. Oral Vaccines Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
